Home > Where Structured Products Really Belong in a Portfolio
|
Structured products are usually sold one at a time.
You’re shown a glossy payoff chart, an impressive coupon, and a soothing word like “protection”. You’re rarely shown the more useful question: “Where does this actually sit in the portfolio you already have?”
This article is about that question: how a sensible investor decides whether a structured product has any business being there at all. And if it does, the next step is in which corner of the portfolio it lives.
Before you even look at a term sheet, you should be able to say what job you’re hiring a product to do.
Three honest “jobs”:
Now the boring but crucial step: could a simple mix of funds and bonds do this already?
A structured product only pulls its weight if it gives you something extra you actually care about. For example, “I want that floor on exactly this date, in one instrument, and I’m willing to pay for it.”
If your real reason is “the coupon is bigger than my savings account and the graph looks tidy”, that’s not a job. That’s just boredom with better branding.
Once you know the job, you decide which bucket it belongs in.
A simple rule:
“If, in the worst case, I can lose equity‑type money, this sits in the equity bucket – however bond‑like the coupon looks.”
In practice:
The mis‑selling disasters tend to start when something that should live in “equity” is placed in “safe”. The statement heading may say “low risk”; the payoff doesn’t read it.
A structured product at 2% of your portfolio is a tool. The same product at 30% is a personality trait.
You don’t need a PhD‑grade model. You just need a few guardrails:
If you wouldn’t put 30% of your wealth in one single share from one company, don’t do the same via that company’s note programme. Same risk, nicer brochure.
Most structured products are a deal between you and a bank that says, roughly: “You leave the money with us. We promise a certain pattern of payoffs. Don’t ask for it back early unless you enjoy disappointing numbers.”
So, at portfolio level, the key question is painfully simple:
“Can I genuinely leave this money alone until the stated maturity date?”
If the answer is “maybe not”, it doesn’t matter how clever the payoff is. You’re relying on a secondary market that is often:
Match the note to money you won’t need for a while. If you might need it for school fees, a house move, or a business wobble, it belongs in cash and plain bonds. Not in a product that only fully makes sense in year five.
Put it all together and the bar becomes clear. It’s not a complicated bar, but it is a bit unforgiving.
A structured product can deserve a seat when:
If you can’t explain it without waving the brochure, if you’re mainly there for the coupon, or if you’re stuffing gaps in the portfolio with products because they look “sophisticated”, the portfolio isn’t getting any smarter. It’s just getting more complicated to regret later.
Structured products aren’t magic beans and they’re not poison. They’re just bond‑plus‑options trades in fancy wrapping, with some extra conditions bolted on.
Used sparingly, in the right corner of a portfolio, by someone who can say in one sentence why the product is there, they can be perfectly decent tools. Used as a short‑cut to “feels safe, pays more than cash”, they’re an expensive way to learn the difference between a promise on a chart and a contract in real life.
If you know which job you’re hiring it for, which bit of your portfolio it’s moving into, and how annoyed you’ll be if it does the worst‑case scenario, you’re already doing more thinking than most of the brochure. At that point, the question isn’t “are structured products good or bad?”, it’s simply whether this particular deal is worth the space you’re giving it.
Stay updated with the latest insights and articles delivered to your inbox weekly.
Stay Informed with Our Updates
Subscribe to our newsletter for the latest insights and expert advice
on funding structures.